Topographical distribution of the anti-apoptotic (cell survival) proteins Bcl-2, Mcl-1 and Bcl-xL in normal and malignant biliary cells detected by immunohistochemistry and immunofluoresence.

被引：0
|
作者：
Okaro, MC [1 ]
Hutchins, R [1 ]
Deery, A [1 ]
Davidson, BR [1 ]
Winslet, MC [1 ]
机构：
[1] Univ London Royal Free Hosp, Dept Surg, London NW3 2QG, England
来源：
GUT | 2000年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
W119
引用
收藏
页码：A62 / A62
页数：1
相关论文
共 50 条
  • [41] Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo
    Carrington, Emma M.
    Zhan, Yifan
    Brady, Jamie L.
    Zhang, Jian-Guo
    Sutherland, Robyn M.
    Anstee, Natasha S.
    Schenk, Robyn L.
    Vikstrom, Ingela B.
    Delconte, Rebecca B.
    Segal, David
    Huntington, Nicholas D.
    Bouillet, Philippe
    Tarlinton, David M.
    Huang, David C. S.
    Strasser, Andreas
    Cory, Suzanne
    Herold, Marco J.
    Lew, Andrew M.
    CELL DEATH AND DIFFERENTIATION, 2017, 24 (05): : 878 - 888
  • [42] Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo
    Emma M Carrington
    Yifan Zhan
    Jamie L Brady
    Jian-Guo Zhang
    Robyn M Sutherland
    Natasha S Anstee
    Robyn L Schenk
    Ingela B Vikstrom
    Rebecca B Delconte
    David Segal
    Nicholas D Huntington
    Philippe Bouillet
    David M Tarlinton
    David CS Huang
    Andreas Strasser
    Suzanne Cory
    Marco J Herold
    Andrew M Lew
    Cell Death & Differentiation, 2017, 24 : 878 - 888
  • [43] Synergistic Activity of Combined Targeting of BCL-2 with MCL-1 or BCL-Xl in B-Cell Precursor All
    Seyfried, F.
    Stirnweiss, F.
    Niedermayer, A.
    Enzenmuller, S.
    Horl, R.
    Kohrer, S.
    Debatin, K. -M.
    Meyer, L.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S161 - S161
  • [44] Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins
    Willis, SN
    Chen, L
    Dewson, G
    Wei, A
    Naik, E
    Fletcher, JI
    Adams, JM
    Huang, DCS
    GENES & DEVELOPMENT, 2005, 19 (11) : 1294 - 1305
  • [45] The anti-apoptotic Bcl-2 family protein Mcl-1 is a pivotal regulator of cell survival in B-cell lymphoma.
    Michels, J
    O'Neill, JW
    Zhang, KYJ
    Craig, RW
    Marcusson, EG
    Johnson, PWM
    Packham, G
    BLOOD, 2003, 102 (11) : 227A - 227A
  • [46] MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-XL, and Mcl-1 and promotes survival of human pancreatic cancer cells
    Boucher, MJ
    Morisset, J
    Vachon, PH
    Reed, JC
    Lainé, J
    Rivard, N
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2000, 79 (03) : 355 - 369
  • [47] Targeting the anti-apoptotic protein Mcl-1 with the mTOR inhibitor RAD001 sensitizes luminal breast cancers to the Bcl-2/Bcl-xL inhibitor ABT-263
    Williams, Michelle M.
    Lee, Linus
    Morrison, Meghan M.
    Williams, Andrew J.
    Sanchez, Violeta
    Hicks, Donna
    Cook, Rebecca
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07)
  • [48] Distribution of Bim Determines MCL-1 Dependence or Co-Dependence on BCL-xL/BCL-2 In Multiple Myeloma.
    Boise, Lawrence H.
    Morales, Alejo A.
    Kurtoglu, Metin
    Matulis, Shannon M.
    Markovitz, Rebecca
    Lee, Kelvin P.
    Lonial, Sagar
    BLOOD, 2010, 116 (21) : 1652 - 1652
  • [49] Estrogen Regulation of Anti-Apoptotic Bcl-2 Family Member Mcl-1 Expression in Breast Cancer Cells
    Schacter, Jennifer L.
    Henson, Elizabeth S.
    Gibson, Spencer B.
    PLOS ONE, 2014, 9 (06):
  • [50] Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B-cell malignancies
    Melvold, Katrine
    Giliberto, Mariaserena
    Karlsen, Linda
    Ayuda-Duran, Pilar
    Hanes, Robert
    Holien, Toril
    Enserink, Jorrit
    Brown, Jennifer R.
    Tjonnfjord, Geir E.
    Tasken, Kjetil
    Skanland, Sigrid S.
    MOLECULAR ONCOLOGY, 2022, 16 (05) : 1153 - 1170
12345